Dolutegravir: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 March 2026

10 March 2026

  • curprev 23:1123:11, 10 March 2026‎ Ostermayer talk contribs‎ 6,356 bytes +6,356‎ Created page with "Dolutegravir is a second-generation integrase strand transfer inhibitor (INSTI) and a preferred first-line agent for HIV-1 treatment. It has a high barrier to resistance and is a component of several common fixed-dose combination tablets.<ref name="TivicayPI">Tivicay (dolutegravir) [prescribing information]. Research Triangle Park, NC: ViiV Healthcare; 2024.</ref> ==Administration== *Type: Integrase strand transfer inhibitor (INSTI) *Dosage Forms:..."
Retrieved from "https://www.wikem.org/wiki/Dolutegravir"